Please enable JavaScript to continue using this application.

Compare $BNTC vs $CYDY | Chartloom

Compare

$BNTC vs $CYDY

Benitec Biopharma Inc · Cytodyn Inc

BNTC

Benitec Biopharma Inc

CYDY

Cytodyn Inc

Compare $BNTC vs $CYDY

Comparing Benitec Biopharma Inc and Cytodyn Inc

BNTCBenitec Biopharma Inc

CYDYCytodyn Inc

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

CYDYCytodyn Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.2%

FCF yield

-6.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BNTC

CYDY

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

CYDY

Cytodyn Inc

Market Cap

BNTC$305M

CYDY$274M

Enterprise Value

BNTC$125M

CYDY$289M

Price

BNTC$8.87

CYDY$0.20

P/E Ratio

BNTCN/A

CYDYN/A

P/S Ratio

BNTC4,474.96x

CYDY0.00x

EV/Sales

BNTC1,903.93x

CYDY0.00x

EV/EBITDA

BNTC0.00x

CYDY34.72x

P/B Ratio

BNTC1.77x

CYDY106.18x

P/FCF Ratio

BNTCN/A

CYDYN/A

EV/FCF

BNTC-7.50x

CYDY-16.77x

PEG Ratio

BNTCN/A

CYDYN/A

Forward P/E (NTM)

BNTCN/A

CYDYN/A

Forward P/S (NTM)

BNTCN/A

CYDYN/A

Revenue (TTM)

BNTC$0

CYDY$0

Revenue Growth (YoY)

BNTCN/A

CYDYN/A

Forward Rev Growth

BNTC13.8%

CYDY0.0%

Gross Margin (TTM)

BNTC100.0%

CYDY0.0%

Operating Margin (TTM)

BNTC0.0%

CYDY0.0%

EBITDA Margin (TTM)

BNTC0.0%

CYDY0.0%

Net Margin (TTM)

BNTC0.0%

CYDY0.0%

FCF Margin (TTM)

BNTCN/A

CYDYN/A

Net Income (TTM)

BNTC$-33M

CYDY$-44M

FCF (TTM)

BNTC$-17M

CYDY$-17M

EPS (TTM)

BNTC$0.00

CYDY-$0.03

ROE (TTM)

BNTC-3482.0%

CYDY-111387.0%

ROA (TTM)

BNTC-3411.0%

CYDY-31117.0%

ROIC (TTM)

BNTC-3482.0%

CYDY-8873.0%

Cash

BNTC$180M

CYDY$12M

Debt

BNTC$0

CYDY$27M

Net Cash/Debt

BNTC$180M

CYDY$-15M

Current Ratio (TTM)

BNTC34.00x

CYDY0.26x

Quick Ratio (TTM)

BNTC33.70x

CYDY0.22x

Debt/Equity (TTM)

BNTC0.00x

CYDY11.55x

Debt/Assets (TTM)

BNTC0.0%

CYDY0.0%

Interest Coverage (TTM)

BNTCN/A

CYDYN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

CYDY0.00x

Beta

BNTC0.23

CYDY1.76

52W Performance

BNTC-37.1%

CYDY-24.2%

YTD Performance

BNTC-29.5%

CYDY-26.0%

% from 52W High

BNTC-47.1%

CYDY-49.6%

% from 52W Low

BNTC4.1%

CYDY9.3%

Asset Turnover (TTM)

BNTC0.01x

CYDY0.00x

FCF Yield (TTM)

BNTC-5.5%

CYDY-6.3%

Earnings Yield (TTM)

BNTC-10.7%

CYDY-16.1%

Dividend Yield (TTM)

BNTCN/A

CYDYN/A

Rule of 40

BNTC0.0

CYDY0.0

EV/GP/RG

BNTCN/A

CYDYN/A

Ticker research

View BNTC research View CYDY research

Metric	BNTC Benitec Biopharma Inc	CYDY Cytodyn Inc
Market & Valuation
Market Cap	$305M	$274M
Enterprise Value	$125M	$289M
Price	$8.87	$0.20
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	34.72x
P/B Ratio	1.77x	106.18x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-16.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	0.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-44M
FCF (TTM)	$-17M	$-17M
EPS (TTM)	$0.00	-$0.03
ROE (TTM)	-3482.0%	-111387.0%
ROA (TTM)	-3411.0%	-31117.0%
ROIC (TTM)	-3482.0%	-8873.0%
Financial Health
Cash	$180M	$12M
Debt	$0	$27M
Net Cash/Debt	$180M	$-15M
Current Ratio (TTM)	34.00x	0.26x
Quick Ratio (TTM)	33.70x	0.22x
Debt/Equity (TTM)	0.00x	11.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.76
52W Performance	-37.1%	-24.2%
YTD Performance	-29.5%	-26.0%
% from 52W High	-47.1%	-49.6%
% from 52W Low	4.1%	9.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-6.3%
Earnings Yield (TTM)	-10.7%	-16.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View CYDY research

Valuation

P/S Ratio

CYDY

0.00x

BNTC

4,474.96x

EV/FCF

CYDY

-16.77x

BNTC

-7.50x

Growth & revenue

Forward Revenue Growth

BNTC

13.8%

CYDY

0.0%

Profitability & performance

Gross Margin

BNTC

100.0%

CYDY

0.0%

ROE

BNTC

-3482.0%

CYDY

-111387.0%

FCF Yield %

BNTC

-5.5%

CYDY

-6.3%

52-Week Performance

CYDY

-24.2%

BNTC

-37.1%

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

CYDY

Cytodyn Inc

Market Cap

BNTC$305M

CYDY$274M

Enterprise Value

BNTC$125M

CYDY$289M

Price

BNTC$8.87

CYDY$0.20

P/E Ratio

BNTCN/A

CYDYN/A

P/S Ratio

BNTC4,474.96x

CYDY0.00x

EV/Sales

BNTC1,903.93x

CYDY0.00x

EV/EBITDA

BNTC0.00x

CYDY34.72x

P/B Ratio

BNTC1.77x

CYDY106.18x

P/FCF Ratio

BNTCN/A

CYDYN/A

EV/FCF

BNTC-7.50x

CYDY-16.77x

PEG Ratio

BNTCN/A

CYDYN/A

Forward P/E (NTM)

BNTCN/A

CYDYN/A

Forward P/S (NTM)

BNTCN/A

CYDYN/A

Revenue (TTM)

BNTC$0

CYDY$0

Revenue Growth (YoY)

BNTCN/A

CYDYN/A

Forward Rev Growth

BNTC13.8%

CYDY0.0%

Gross Margin (TTM)

BNTC100.0%

CYDY0.0%

Operating Margin (TTM)

BNTC0.0%

CYDY0.0%

EBITDA Margin (TTM)

BNTC0.0%

CYDY0.0%

Net Margin (TTM)

BNTC0.0%

CYDY0.0%

FCF Margin (TTM)

BNTCN/A

CYDYN/A

Net Income (TTM)

BNTC$-33M

CYDY$-44M

FCF (TTM)

BNTC$-17M

CYDY$-17M

EPS (TTM)

BNTC$0.00

CYDY-$0.03

ROE (TTM)

BNTC-3482.0%

CYDY-111387.0%

ROA (TTM)

BNTC-3411.0%

CYDY-31117.0%

ROIC (TTM)

BNTC-3482.0%

CYDY-8873.0%

Cash

BNTC$180M

CYDY$12M

Debt

BNTC$0

CYDY$27M

Net Cash/Debt

BNTC$180M

CYDY$-15M

Current Ratio (TTM)

BNTC34.00x

CYDY0.26x

Quick Ratio (TTM)

BNTC33.70x

CYDY0.22x

Debt/Equity (TTM)

BNTC0.00x

CYDY11.55x

Debt/Assets (TTM)

BNTC0.0%

CYDY0.0%

Interest Coverage (TTM)

BNTCN/A

CYDYN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

CYDY0.00x

Beta

BNTC0.23

CYDY1.76

52W Performance

BNTC-37.1%

CYDY-24.2%

YTD Performance

BNTC-29.5%

CYDY-26.0%

% from 52W High

BNTC-47.1%

CYDY-49.6%

% from 52W Low

BNTC4.1%

CYDY9.3%

Asset Turnover (TTM)

BNTC0.01x

CYDY0.00x

FCF Yield (TTM)

BNTC-5.5%

CYDY-6.3%

Earnings Yield (TTM)

BNTC-10.7%

CYDY-16.1%

Dividend Yield (TTM)

BNTCN/A

CYDYN/A

Rule of 40

BNTC0.0

CYDY0.0

EV/GP/RG

BNTCN/A

CYDYN/A

Ticker research

View BNTC research View CYDY research

Metric	BNTC Benitec Biopharma Inc	CYDY Cytodyn Inc
Market & Valuation
Market Cap	$305M	$274M
Enterprise Value	$125M	$289M
Price	$8.87	$0.20
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	34.72x
P/B Ratio	1.77x	106.18x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-16.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	0.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-44M
FCF (TTM)	$-17M	$-17M
EPS (TTM)	$0.00	-$0.03
ROE (TTM)	-3482.0%	-111387.0%
ROA (TTM)	-3411.0%	-31117.0%
ROIC (TTM)	-3482.0%	-8873.0%
Financial Health
Cash	$180M	$12M
Debt	$0	$27M
Net Cash/Debt	$180M	$-15M
Current Ratio (TTM)	34.00x	0.26x
Quick Ratio (TTM)	33.70x	0.22x
Debt/Equity (TTM)	0.00x	11.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.76
52W Performance	-37.1%	-24.2%
YTD Performance	-29.5%	-26.0%
% from 52W High	-47.1%	-49.6%
% from 52W Low	4.1%	9.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-6.3%
Earnings Yield (TTM)	-10.7%	-16.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View CYDY research